Check out what we have done with our previous project and what the scope looks like for the future, as well as any latest developments.

What we are doing..


The RiHN team is actively involved in shaping the domain of Redistributed Manufacturing (RDM) and Distributed Manufacturing (DM) in Healthcare. Our investigators cover a diverse range of disciplines and adopt a systems view of RDM development, commercialisation, implementation and operational support. Our research covers a range of themes such as:

  • Healthcare Policy and Regulation Strategy,
  • Operations and Innovation Management
  • Engineering and Technology
  • Management Personalised and Precision Medicine
  • Additive Manufacturing and Bioprinting
  • Advanced Therapy Medicinal Products (ATMPs), including Cell, Gene and Tissue
  • Advanced Manufacturing in Pharmaceuticals

What we did..

At the end of our last project we created ‘The RiHN White Paper’ it is the first serious attempt to gather expertise and to explore applications in promising areas of healthcare that could benefit from RDM and covers early-stage user needs, challenges and priorities. The paper served as a foundation for discussing future technological roadmaps and engaging the wider community and stakeholders, as well as policy makers, in addressing the potential impact of RDM.

Please see below videos of our past funded feasibility studies

Further Reading

See below publications/reports from the RiHN Team:

  • Phillips, W., Kapletia, D., Dalgarno, K., Hunt, P., Bibb, R., Makatsoris, H., Rafiq, Q., Roscoe, S., Omar, B., Willoughby, N., Paterson, A., Benger, J. (2020) Innovation in healthcare manufacturing: transforming deployed medical care, International Society for Professional Innovation Management (ISPIM), Virtual Conference, June 2020.
  • Hunt, P., Kapletia, D. (2019) Redistributed manufacturing to support field medical care. Future Healthcare Journal, 6(1), 64–65 Read More..
  • Ghani, A., Srai, J.S. (2018) Identifying institutional mechanisms for innovations and regulatory changes within the pharmaceutical sec, Production and Operations Management Society (POMS) 2018 International Conference.
  • Thurman-Newell, J.A., Harrison, R., Hourd, P., Petzing, J., Rafiq, Q.A., Medcalf, N. (2016) Cell micro-factories: Feasibility of a redistributed manufacturing model for cell based therapeutics. In: EurOMA 2016 (23rd International Annual Conference of the European Operations Management Association), 17-22 Jun 2016, Trondheim, Norway

  • Roscoe, S., Blome, C. (2016) A framework for the adoption of redistributed manufacturing in pharmaceutical supply chains. In: EurOMA 2016 (23rd International Annual Conference of the European Operations Management Association), 17-22 Jun 2016, Trondheim, Norway
  • Adamietz R, Giesen T, Mayer P, Johnson A, Bibb R, Seifarth C (2018), “Reconfigurable and transportable ‎container-integrated production system”, Robotics & Computer Integrated Manufacturing. Read more..

  • Phillips, W., Roehrich, J., Kapletia, D. and Alexander, E. 2022. 'Global Value Chain Reconfiguration and COVID-19: Investigating the Case for More Resilient Redistributed Models of Production.' California Management Review,. Read more..
  • Fosso Wamba, S., Queiroz, M.M., Roscoe, S., Phillips, W., Kapletia, D. and Azadegan, A. (2021), "Guest editorial Emerging technologies in emergency situations", International Journal of Operations & Production Management, Vol. 41 No. 9, pp. 1405-1416. Read more.. 
  • Wendy Phillips, Jens K. Roehrich & Dharm Kapletia (2021) Responding to information asymmetry in crisis situations: innovation in the time of the COVID-19 pandemic, Public Management Review, DOI: 10.1080/14719037.2021.1960737 Read more..
  • Srai, J.S., Graham, G., Hennelly, P., Phillips, W., Kapletia, D. and Lorentz, H. (2020). Distributed manufacturing: a new form of localised production? International Journal of Operations & Production Management. Read More..
  • Srai, J.S., Graham, G., Hennelly, P., Phillips, W., Kapletia, D., Lorentz, H. (Forthcoming) Distributed Manufacturing: A new form of localized production? International Journal of Operations and Production Management, Accepted April 2020
  • Kapletia, D., Phillips, W., Medcalf, N., Makatsoris, H., McMahon, C., Rich, N. (2019) Redistributed manufacturing–challenges for operations management. Production Planning & Control, 30(7), 493-495 Read More
  • Medcalf, N. (2019) Decentralized manufacture of cell therapies: the challenge of operational modelling. Cell and Gene Therapy Insights, 5(10), 1133-1149 Read More..
  • Roscoe, S., Blome, C. (2019) Understanding the emergence of redistributed manufacturing: an ambidexterity perspective. Production Planning & Control, 30(7), 496-509 Read More..
  • Harrison, R.P., Rafiq, Q., Medcalf, N. (2018) Centralised versus decentralised manufacturing and the delivery of healthcare products: A United Kingdom exemplar. Cytotherapy, 20(6), 873-890 Read More..
  • Montalbano, G., Toumpaniari, S., Popov, A., Duan, P., Chen, J., Dalgarno, K., Scott, W.E. III, Ferreira, A.M. (2018) Synthesis of bioinspired collagen/alginate/fibrin based hydrogels for soft tissue engineering. Materials Science and Engineering, 91, 236-246 Read More..
  • Harrington, T.S., Phillips, M.A., Srai, J.S. (2017) Reconfiguring global pharmaceutical value networks through targeted technology interventions. International Journal of Production Research, 55(5), 1471-1487 Read More..
  • Srai, J., Kumar, M., Graham, G., Phillips, W., Tooze, J., Ford, S., Beecher, P., et al. (2016) Distributed manufacturing: scope, challenges and opportunities. International Journal of Production Research, 54(23), 6917-6935 Read More..
  • Srai, J.S., Harrington, T., Alinaghian, L. and Phillips, M. (2015) Evaluating the potential for the continuous processing of pharmaceutical products—a supply network perspective. Chemical Engineering and Processing: Process Intensification, 97, 248-258 Read More..

  • Today Show. 2020. BBC Radio 4. 18 August, (2h 46m into the programme) - Professor Harris Makatsoris discussing developing a ‘factory-in-a-box’, that allows the rapid manufacture of synthetic RNA vaccines against the SARS-CoV-2 virus and minimises the space required for high-volume vaccine production.
  • Bibb, R., 2020. Expert’s Corner: Additive Manufacturing Response to COVID Crisis. [Blog] 3DHeals, Available at: https://3dheals.com/3d-printing-for-covid-19-crisis
  • Makatsoris, H., 2020. Engineering awards for transformative work during the COVID-19 pandemic. [Blog] Design Products & Applications, Available at: Read More..
  • Makatsoris, H., 2020. Spotlight on COVID: How engineering is contributing to vaccine manufacture.Watch here..
  • Gagan, O., 2020. Reshoring: The Secret To Post-COVID Manufacturing?. [online] Raconteur.  Read More..